Roles of T Helper 1 Cytokines in Type 1 Diabetes
NCT02389335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128
Last updated 2015-03-17
Summary
The mechanism of β cell destruction in Type 1 diabetes is not exactly known, Our hyphotesis is that interferon gamma, interleukin-2 and tumor necrotizan factor alpha have impotant roles in β cell destruction.
Conditions
Sponsors & Collaborators
-
Istanbul Medeniyet University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2014-07-31
- Completion
- 2014-11-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Identification of β Cell Dysfunction in Relatives of Individuals With Type 1 Diabetes Mellitus
NCT04362917 ·Status: COMPLETED
-
Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 Diabetes
NCT05159856 ·Status: RECRUITING
-
Low Grade Inflammation in Type 1 Diabetes Children
NCT01099956 ·Status: COMPLETED
-
The Effect of Oxytocin on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 Diabetes
NCT06881459 ·Status: COMPLETED ·Phase: NA
-
Activation Innate Immune System in Type 1 Diabetes
NCT03441919 ·Status: COMPLETED
-
Role of TMEM219 Marker in Type 1 Diabetes
NCT03794739 ·Status: UNKNOWN
-
Prospective Assessment in Newborns for Diabetes Autoimmunity
NCT00649246 ·Status: COMPLETED
-
Association of Systemic Immune-inflammation Index and Severity of Diabetic Ketoacidosis in Type 1 Diabetes Mellitus
NCT06251895 ·Status: COMPLETED
-
Covid-19 Infection and New Onset Type 1 Diabetes
NCT04623697 ·Status: RECRUITING
-
The Effect of Rapid and Slow Glucose Fall on the Subsequent Glucose Production in People With Type 1 Diabetes
NCT04098549 ·Status: COMPLETED ·Phase: NA
-
Risk Factors for Atherogenesis in Type 1 Diabetes
NCT00035750 ·Status: COMPLETED
-
Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease
NCT06849622 ·Status: RECRUITING ·Phase: NA
-
Infections and Latent Autoimmune Diabetes in Adults
NCT06167616 ·Status: COMPLETED
-
TrialNet Pathway to Prevention of T1D
NCT00097292 ·Status: RECRUITING
-
Glucose-stimulated Pancreatic Islet and Intestinal Blood Flow in Healthy Subjects and in Type 1 Diabetes
NCT02547337 ·Status: COMPLETED
-
Vascular Inflammation in Adolescents With Type 1 Diabetes
NCT00933101 ·Status: COMPLETED
-
Immune Profile in Subjects With New Onset Type 1 Diabetes
NCT02801942 ·Status: COMPLETED ·Phase: NA
-
Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 As Biomarkers of AKI in Children With DKA
NCT06032325 ·Status: UNKNOWN
-
Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 Diabetes
NCT01280682 ·Status: COMPLETED ·Phase: PHASE4
-
Intensive Insulin Treatment and Ischemic Foot Ulcer
NCT01957930 ·Status: COMPLETED ·Phase: NA
-
The Link Between "Time In Range" Versus HbA1c and the Presence of Chronic COmplications in Type 1 Diabetes: a Longitudinal Study
NCT05530369 ·Status: COMPLETED
-
Long Term Vascular Changes in Type 1 Diabetes
NCT00991575 ·Status: COMPLETED
-
Effect of Methyldopa on MHC Class II Antigen Presentation in Type 1 Diabetes
NCT01883804 ·Status: COMPLETED ·Phase: NA
-
Early Detection of Type 1 Diabetes
NCT06984185 ·Status: RECRUITING
-
Recurrent Hypoglycaemia in Type 1 Diabetes
NCT01337362 ·Status: COMPLETED ·Phase: NA